Canada, Montreal: Molson Inc. confirmed on July 28 that Robert A. Ingram has submitted his resignation from the Corporation's Board of Directors.

Robert A. Ingram, who is Vice Chairman Pharmaceuticals of GlaxoSmithKline made the decision to resign based on "an ever increasing workload and other commitments." Mr. Ingram also sits on the Boards of Edwards Life Sciences, Lowe's Companies, Inc., Misys plc, Nortel Networks Corporation, OSI Pharmaceuticals, Inc., Wachovia Corporation and Valeant Pharmaceuticals. In addition, he is a member of numerous civic and professional organizations.

"I am grateful for the opportunity to have worked with the independent directors at Molson and am hopeful that, with their guidance, the Board will continue to act in the best interests of all shareholders," explained Mr. Ingram.

The Chairman of Molson, Eric H. Molson, expressed his gratitude for Mr. Ingram's commitment and work over the past years, including his guidance within the Audit and Finance Committee. Mr. Ingram was also a member of the Special Committee of Independent Directors that unanimously recommended the proposed merger between Molson Inc. and Adolph Coors Company. Molson will not proceed to replace Mr. Ingram immediately on the Board.

Molson Inc. is one of the world's largest brewers of quality beer with operations in Canada, Brazil and the United States. A global brewer with $3.5 billion in gross annual sales, Molson traces its roots back to 1786 making it North America's oldest beer brand. Committed to brewing excellence, Molson combines the finest natural ingredients with the highest standards of quality to produce an award-winning portfolio of beers including Molson Canadian, Molson Export, Molson Dry, Rickard's, Marca Bavaria, Kaiser and Bavaria.

31 July, 2004